Application Note: IHC-P: 2-6μg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 185
Positive Control: The peptide used to generate this antibody is available for purchase (GTX94119-PEP).
Specificity/Sensitivity: This antibody is expected to recognize all 3 reported isoforms (as represented by NP_001009881.1; NP_056084.1; NP_001009882.1)
Form: Liquid
Buffer (with preservative): TBS, 0.5% BSA, 0.02% Sodium azide.
Concentration: 0.50 mg/ml (Please refer to the vial label for the specific concentration.)
Background: ZCCHC11 is an RNA uridyltransferase (EC 2.7.7.52) that uses UTP to add uridines to the 3-prime end of substrate RNA molecules (Jones et al., 2009 [PubMed 19701194]).[supplied by OMIM, Jan 2011]
Uniprot ID: Q5TAX3
Antigen Species: Human
Immunogen: Peptide with sequence RERCPHPPRGNVSE, from the C Terminus of the protein sequence according to NP_001009881.1; NP_056084.1; NP_001009882.1.
Purification: Purified by ammonium sulphate precipitation followed by antigen affinity chromatography
Conjugation: Unconjugated
Full Name: terminal uridylyl transferase 4